Skip to main content

Table 4 Associations between sleep complaints, hypnotics use, and incidence of dementia with vascular component over a 12-year follow-up

From: Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderly

Variables

Whole sample

Incident DVC

n = 6295

No, n = 6156

Yes, n = 139

Model 1a

Model 2b

Model 3c

n

%

n

%

n

%

HR [95%CI]d

p

HR [95%CI]d

p

HR [95%CI]d

p

Excessive daytime sleepiness (EDS)

0.001

 

0.008

 

0.02

 No

5186

82.38

5090

82.68

96

69.06

1

 

1

 

1

 

 Yes

1109

17.62

1066

17.32

43

30.94

1.87 [1.28–2.74]

 

1.68 [1.15–2.47]

 

1.58 [1.07–2.32]

 

Difficulty with initiating sleep (DIS)

0.52

 

0.63

 

0.99

 No

4098

65.10

4018

65.27

80

57.55

1

 

1

 

1

 

 Yes

2197

34.90

2138

34.73

59

42.45

1.13 [0.78–1.62]

 

1.09 [0.76–1.58]

 

1.00 [0.69–1.45]

 

Difficulty in maintaining sleep (DMS)

0.62

 

0.98

 

0.78

 No

2290

36.38

2247

36.50

43

30.94

1

 

1

 

1

 

 Yes

4005

63.62

3909

63.50

96

69.06

1.10 [0.76–1.58]

 

1.01 [0.69–1.45]

 

0.95 [0.66–1.37]

 

Early morning awakening (EMA)

0.64

 

0.56

 

0.38

 No

4006

63.64

3921

63.69

85

61.15

1

 

1

 

1

 

 Yes

2289

36.36

2235

36.31

54

38.85

0.92 [0.64–1.31]

 

0.90 [0.63–1.29]

 

0.85 [0.60–1.22]

 

Sleep quality (SQ)

0.37

 

0.27

 

0.08

 Good

2692

47.53

2630

47.46

62

50.41

1

 

1

 

1

 

 Bad

2972

52.47

2911

52.54

61

49.59

0.85 [0.59–1.21]

 

0.82 [0.57–1.17]

 

0.72 [0.50–1.04]

 

Clinical severity sleepe (CSS)

6.18 (±3.22)

6.17 (±3.22)

6.53 (±3.05)

0.99 [0.94–1.05]

0.81

0.98 [0.92–1.04]

0.46

0.96 [0.90–1.02]

0.15

Clinical severity sleep (CSS)

0.06

 

0.09

 

0.06

 [0; 4]

1922

33.93

1893

34.16

29

23.58

1

 

1

 

1

 

 [4; 7.5]

2019

35.65

1961

35.39

58

47.15

1.58 [1.00–2.48]

 

1.41 [0.89–2.22]

 

1.30 [0.83–2.06]

 

 > 7.5

1723

30.42

1687

30.45

36

29.27

1.03 [0.62–1.72]

 

0.91 [0.55–1.52]

 

0.79 [0.47–1.33]

 

Hypnotic use

0.02

 

0.04

 

0.26

 No

4929

78.30

4833

78.51

96

69.06

1

 

1

 

1

 

 Yes

1366

21.70

1323

21.49

43

30.94

1.52 [1.06; 2.18]

 

1.46 [1.01–2.11]

 

1.24 [0.85–1.81]

 
  1. aAdjusted for study center, sex, mobility, and presence of the APOE-ε4 allele, stratified for the level of education
  2. bAdjusted for all covariates in model 1 plus diabetes mellitus, body-mass index, and cardiovascular disease
  3. cAdjusted for all covariates in model 2 plus depressive status
  4. dEstimated using Cox proportional hazard models with delayed entry and age as the time scale
  5. eContinuous variables were expressed as mean (standard deviation)